Research programme: sarcopenia therapeutics - Satellos Bioscience
Latest Information Update: 04 Jan 2024
At a glance
- Originator Satellos Bioscience
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Sarcopenia
Most Recent Events
- 04 Dec 2023 Early research in Sarcopenia (Prevention) in Canada (unspecified route) prior to December 2023 (Satellos Bioscience pipeline, December 2023)
- 04 Dec 2023 Early research in Sarcopenia in Canada (unspecified route) prior to December 2023 (Satellos Bioscience pipeline, December 2023)